Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.

Ming-Lun YehChung-Feng HuangMeng-Hsuan HsiehYu-Min KoKuan-Yu ChenTa-Wei LiuYi-Hung LinPo-Cheng LiangMing-Yen HsiehZu-Yau LinShinn-Cherng ChenChing-I HuangJee-Fu HuangPo-Lin KuoChia-Yen DaiMing-Lung YuWan-Long Chuang

Published in: Journal of gastroenterology and hepatology (2018)

There was a minimal impact of hepatitis B core antibody seropositivity on HCV efficacy and safety. For CHC patients with current HBV infection, the risk of HBV reactivation was present, and monitoring the HBV DNA level during therapy is warranted.

Keyphrases

hepatitis b virus
liver failure
end stage renal disease
newly diagnosed
ejection fraction
hepatitis c virus
peritoneal dialysis
stem cells
circulating tumor
human immunodeficiency virus
bone marrow
patient reported
cell therapy
nucleic acid